There are three genomic tests. Our researchers will use existing tumour core samples (you will not need to have them resampled) and a new blood sample to conduct the tests. These samples will be taken and then sent to the lab to be tested.

So, what are the three tests?

The Somatic tumour panel tests your DNA for variations linked to cancer. These are changes (variations) in the DNA that are not inherited and have occurred after a person was conceived. This test requires a sample of the tumour core. This sample will be tested at our lab in Melbourne.

The germline panel involves testing for variations in the DNA that exists in sperm cells. These changes (variations) in the DNA might be inherited or shared with other family members. This test requires a blood sample, which will also be sent to our lab in Melbourne.

The final test is the Decipher Risk score determination and evaluation. This test requires a sample of the tumour core to be sent to a partner lab in San Francisco. It looks for variations in the DNA that can help identify if tumours are more or less likely to spread outside the prostate.  It returns a risk score of this likelihood.